How it works

The SyMRI® technology is based on rapid MR quantification of the patient’s physical properties. Using the SyMRI approach, a single, short MRI quantification scan measures physical properties of the patient. Using this data, conventional contrast images can be synthesized at any combination of TR, TE and inversion delay time TI. This provides a short scan time and a robust and flexible examination since a whole range of images can be synthesized even after the patient has left. Furthermore tissues can be recognized automatically with synthetic tissue mapping, providing objective, quantitative, decision support.



Practical workflow

Your MRI scanner will receive a software update to produce the required scan. This is a protocol just like any other. It will produce the raw images required for MR quantification. The images are sent to PACS or a workstation. The SyMRI quantification module translates the raw images into SyMaps™ (the T1 and T2 relaxation and proton density maps). The SyMaps are input for the SyMRI post-processing software for synthetic MRI and synthetic tissue mapping. All synthetic images can be stored locally or sent back to PACS.


Market availability

Using SyMRI, clinicians can capture multiple image contrasts in a single scan, providing an efficient workflow and the possibility of examining more patients per day. With synthetic MRI, the contrast can be adjusted after the scan, creating additional images without re-calling the patient. Automatic segmentation of brain tissue provides objective decision support based on quantitative data.

SyMRI is a CE-marked product, available in the product packages SyMRI IMAGE, SyMRI NEURO and SyMRI NEURO REMyDI. SyMRI IMAGE is FDA cleared. SyMRI is also available in a Research Edition package.

SyMRI is a registered trademark in Europe and USA.